David Cortez, PhD, Richard N. Armstrong, PhD, Professor of Innovation in Biochemistry and professor of Biochemistry, has been appointed chair of the Department of Biochemistry.

Vanderbilt University School of Medicine officially welcomed 96 first-year students to its ranks with its annual White Coat ceremony, held July 23.

Following a national leadership search, Srijaya Reddy, MD, MBA, has been named chief of the Division of Pediatric Anesthesiology in the Department of Anesthesiology at Vanderbilt University Medical Center.

A report of more than 23,000 health care workers and employees at Vanderbilt University Medical Center who received the Pfizer-BioNTech mRNA COVID-19 vaccine shows that a risk stratification screening mechanism for potential allergies to the vaccine worked exceedingly well as the vaccine program rolled out in December 2020.

Mary Pawlikowski, MA, MEd, interim vice president and chief operating officer for Vanderbilt Psychiatric Hospital (VPH), has been named as the hospital’s new president after having held the position of president on an interim basis since November 2020.

An immediate allergic reaction to the first dose of an mRNA COVID-19 vaccine — those manufactured by Moderna and Pfizer BioNTech — should not keep people from getting the second dose, a multi-hospital analysis shows.

Vanderbilt University Medical Center researchers, supported by the National Institutes of Health (NIH), are leading a nationwide clinical trial to explore the safety and effectiveness of a group of novel drugs designed to protect patients hospitalized with COVID-19 at high risk of poor outcomes.